Erratum to Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration (J. Med. Toxicol, 10.1007/s13181-012-0275-6);Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration

Journal of Medical Toxicology

Volumn 9, Issue 2, 2013, Pages 139-143

  Levine, Michael ^a   Swenson, Steve ^b   McCormick, Taylor ^a   Henderson, Sean O ^a   Thomas, Stephen H ^c   Markland, Francis S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Bleeding; Clopidogrel; DDAVP; Desmopressin; Overdose

Indexed keywords

CLOPIDOGREL; DESMOPRESSIN; PLACEBO; SODIUM CHLORIDE; THIENOPYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; DRUG OVERDOSE; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; THROMBUS;

EID: 84878108366     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-013-0308-9     Document Type: Erratum

References (19)

1. Kolansky DM (2009) Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care 15(2Suppl): S36-41.
2. Corti R, Fuster V, Badimon JJ (2003) Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 41: 7-14.
3. Valgimigli M, Minarelli M (2011) Triple antiplatelet therapy in acute coronary syndromes. Drugs 71: 1703-19.
4. Furie B (2009) Pathogenesis of thrombosis. Hematology Am Soc Hematol Educ Program 255-258.
5. Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359: 938-49.
6. Angiolillo DJ, Capodanno D, Goto S (2010) Platelet thrombin receptor antagonism and atherothrombosis. Eur Heart J 31: 17-28.
7. Murugappa S, Kunapuli SP (2006) The role of ADP receptors in platelet function. Front Biosci 11: 1977-86.
8. Wallentin L (2009) P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J. 30: 1964-77.
9. Plosker GL, Lyseng-Williamson KA (2007) Clopidogrel: a review of its use in the prevention of thrombus. Drugs 67: 613-46.
10. Berndt MC, Ward CM, DeLuca M et al (1995) The molecular mechanism of platelet adhesion. Aust NZ J Med 25: 822-30.
11. Arora RR, Rai F (2009) Antiplatelet intervention in acute coronary syndrome. Am J Ther 16: e29-40.
12. Angiolillo DJ (2007) ADP receptor antagonistm: what's in the pipeline? Am J Cardiovasc Drugs 7: 423-32.
13. Coppola A, DiMinno G (2008) Desmopressin in inherited disorders of platelet function. Haemophilia 14(Suppl 1): 31-9.
14. Franchini M (2007) The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 82: 731-5.
15. Leithauser B, Zielske D, Seyfert UT et al (2008) Effects of desmopressin on platelet membrane glycoproteins and platelet aggregation in volunteers on clopidogrel. Clin Hemorheol Microcirc 39: 293-302.
16. Naucel FE, de Moraes E, Penido C et al (2004) Massive nasal bleeding and hemodynamic instability associated with clopidogrel. Pharm World Sci 26: 6-7.
17. Von Heymann C, Schoenfeld H, Sander M et al (2005) Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: a rationale for the use of coagulation factor concentrates? Heart Surg Forum 8: E39-41.
18. Ranucci M, Nano G, Pazzaglia A et al (2007) Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. J Cardiothorac Vasc Anesth 21: 851-4.
19. Hochholzer W, Trenk D, Frundi D et al (2005) Time dependence of platelet inhibition after 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 111: 2560-4.